关注
Jorge S. Valadas
Jorge S. Valadas
Muna Therapeutics
在 munatherapeutics.com 的电子邮件经过验证
标题
引用次数
年份
Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants
G Esposito, M Vos, S Vilain, J Swerts, J De Sousa Valadas, ...
Plos genetics 9 (4), e1003478, 2013
772013
Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
VL Batalha, JM Pêgo, BM Fontinha, AR Costenla, JS Valadas, Y Baqi, ...
Molecular psychiatry 18 (3), 320-331, 2013
1602013
An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia
M Padmakumar, S Biesmans, JS Valadas, JR Detrez, G Gillet, P Bresler, ...
Frontiers in Drug Discovery 3, 1289314, 2023
2023
Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: Therapeutic implications for ALS
ML Clénet, J Keaney, G Gillet, JS Valadas, J Langlois, A Cardenas, ...
Frontiers in Immunology 14, 1190219, 2023
22023
ER lipid defects in neuropeptidergic neurons impair sleep patterns in Parkinson’s
JS Valadas, G Esposito, D Vandekerkhove, K Miskiewicz, L Deaulmerie, ...
ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson’s Disease
JS Valadas, G Esposito, D Vandekerkhove, K Miskiewicz, L Deaulmerie, ...
Neuron, 2018
972018
Escitalopram improves memory deficits induced by maternal separation in the rat
FS do Couto, VL Batalha, JS Valadas, J Data-Franca, JA Ribeiro, ...
European journal of pharmacology 695 (1-3), 71-75, 2012
422012
HDAC6 is a Bruchpilot deacetylase that facilitates neurotransmitter release
K Miskiewicz, LE Jose, WM Yeshaw, JS Valadas, J Swerts, S Munck, ...
Cell Reports 8 (1), 94-102, 2014
442014
Innate immune activation and aberrant function in the R6/2 mouse model and Huntington’s disease iPSC-derived microglia
J Gasser, G Gillet, JS Valadas, L Rouvière, A Kotian, W Fan, J Keaney, ...
Frontiers in molecular neuroscience 16, 1191324, 2023
12023
MAPRE2 mutations result in altered human cranial neural crest migration, underlying craniofacial malformations in CSC-KT syndrome
C Thues, JS Valadas, L Deaulmerie, A Geens, AK Chouhan, ...
Scientific reports 11 (1), 4976, 2021
112021
Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin‐releasing factor (CRF) in glutamate injured cortical neurons
JS Valadas, VL Batalha, DG Ferreira, R Gomes, JE Coelho, AM Sebastião, ...
Journal of neurochemistry 123 (6), 1030-1040, 2012
362012
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
JE Coelho, P Alves, PM Canas, JS Valadas, T Shmidt, VL Batalha, ...
Frontiers in psychiatry 5, 67, 2014
1142014
Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety. Front Psychiatry 5: 67
JE Coelho, P Alves, PM Canas, JS Valadas, T Shmidt, VL Batalha, ...
62014
p13 protects against Parkinson's disease
JS Valadas, P Verstreken
EMBO reports 19 (3), e45900, 2018
12018
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function
VL Batalha, DG Ferreira, JE Coelho, JS Valadas, R Gomes, ...
Scientific Reports 6 (1), 31493, 2016
612016
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
JS Valadas, M Vos, P Verstreken
Annals of the New York Academy of Sciences 1338 (1), 16-37, 2015
472015
系统目前无法执行此操作,请稍后再试。
文章 1–16